Skin closure surgery tissue adhesive DERMABOND™ PRINEO™
2-octyl cyanoacrylate

skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
skin closure surgery tissue adhesive
Add to favorites
Compare this product
 

Characteristics

Applications
skin closure surgery
Composition
2-octyl cyanoacrylate

Description

DERMABOND PRINEO System combines a liquid adhesive with a self-adhering mesh (latex free) for closure of surgical incisions and simple lacerations. It is a non-invasive alternative to skin sutures and staples. DERMABOND PRINEO combines the proven strength, flexibility, and microbial barrier of DERMABOND ADVANCED™ with the security of a self-adhering mesh to facilitate skin closure and an optimal healing environment.A1-7 In a clinical study, DERMABOND PRINEO System was associated with a better cosmetic outcome than conventional suturing in skin closure. About this Device DERMABOND™ PRINEO™ Skin Closure System is a sterile, liquid topical skin adhesive. It also incorporates a self-adhering mesh that is applied to the approximated skin edges to provide temporary skin edge alignment until the liquid adhesive is applied to achieve skin closure. It forms a strong, flexible, waterproof microbial barrier—as long as the adhesive film remains intact—that falls off naturally after 7-14 days. Economic Outcomes In a retrospective study comparing TJA patients with conventional closure to those who had multilayer watertight closure with STRATAFIX™ Knotless Tissue Control Devices and DERMABOND PRINEO Skin Closure System, statistically significant advantages were shown for multilayer watertight closure patients includingC9: Shorter LOS (0.5 days) No reoperations within 90 days Higher percent of patients discharged to home Extended time to readmission Economic Outcomes In a retrospective study comparing TJA patients with conventional closure to those who had multilayer watertight closure with STRATAFIX™ Knotless Tissue Control Devices and DERMABOND PRINEO Skin Closure System,
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.